31 results on '"Dumortier, Jerome"'
Search Results
2. Recurrent splanchnic and extrasplanchnic thrombotic events in patients with non-cirrhotic portal vein thrombosis associated with local factors
3. Evaluation of a delayed liver transplantation strategy for patients with HCC receiving bridging therapy: the DELTA-HCC study
4. Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis
5. Preventive administration of UDCA after liver transplantation for primary biliary cirrhosis is associated with a lower risk of disease recurrence
6. WED-391 Long-term virological and clinical outcomes of patients with HDV-related compensated cirrhosis treated with bulevirtide monotherapy for up to 120 weeks: a retrospective multicenter european study (save-d)
7. FRI-370 Bulevirtide efficacy and safety in chronic hepatitis delta patients on liver transplant waiting list
8. WED-129 Abdominal surgery in patients with chronic noncirrhotic extra hepatic portal vein obstruction: a multicenter retrospective case-control study
9. SAT-048 Long-term mortality and risk factors associated with mortality after liver transplantation in the modern era
10. SAT-010 Elaboration of a one-year mortality score for first elective liver transplantation recipients over 60 years based on the results of the french national cohort between 2007 and 2017
11. TOP-005 Immune checkpoint inhibitors after liver transplantation: the key role of immunosuppression management
12. OS-120 Bulevirtide monotherapy prevents liver decompensation and reduces mortality in patients with HDV-related cirrhosis: a case control study with propensity score weighted analysis
13. OS-022 Kinetics of immunedysfunction in liver transplanted patients and impact on clinical outcome
14. GS-010 Early liver transplantation for severe alcohol-related hepatitis: long-term data of the french-belgian controlled study (QuickTrans)
15. THU-380 - State of knowledge of alpha 1 anti-trypsin deficiency among practitioners specialized in liver transplantation in France : a national survey
16. THU-511 - Long-term outcome following liver transplantation for chronic liver disease in intensive care unit: the French nationwide experience
17. THU-498 - Evaluation of a delayed liver transplant strategy for patients listed for hepatocellular carcinoma treated with resection or thermo-ablation as a bridge to liver transplantation; the DELTAS-HCC study
18. FRI-443 - Hemoglobin is a short-term prognostic factor in decompensated alcohol-associated cirrhosis: a multicenter prospective study
19. LBP-11 - Virological and clinical outcomes of patients with HDV-related compensated cirrhosis treated with Bulevirtide monotherapy: the retrospective multicenter European study (Save-D)
20. OS-073 - Prognostic significance of liver stiffness progression in primary biliary cholangitis
21. OS-083-YI - Natural history and management of recurrent hepatocellular carcinoma after liver transplantation: a multicenter nationwide study
22. OS-080-YI - Platelet, elastography, age, sex and etiology for hepatocellular carcinoma surveillance in patients with advanced chronic liver disease: Please algorithm
23. OS-066 - HDV-RNA decline less than 1 log after 6 months of BLV 2 mg monotherapy could define poor-response and lead to therapeutic decision. Data from real-life cohort
24. Hepatitis B virus reactivation in transplant patients treated for hepatitis C recurrence: Prophylaxis makes the difference
25. Endothelial cell differentiation in hepatocellular adenomas: implications for histopathological diagnosis
26. Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa-2b and ribavirin combination
27. Endothelial cell marker expression in dysplastic lesions of the liver: an immunohistochemical study
28. THU-152-New in France: Universal access for HCV-treatment as demonstrated by a nationwide real-world cohort
29. GS-18-Preventive administration of ursodeoxycholic acid after liver transplantation for primary biliary cholangitis prevents disease recurrence and prolongs graft survival
30. PS-121 - Prognosis of ALF of unknown cause: results of the French multicentre prospective HASIPRO study
31. HBV reactivation in the recipient of a liver graft from an anti-HBc positive donor despite post-vaccination antibodies to hepatitis B surface antigen
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.